Microbiology of diabetic foot infections: from Louis Pasteur to ‘crime scene investigation’
BMC Medicine 2015, 13:2 (7 January 2015)
Current methods to identify pathogens causing diabetic foot infections (DFIs) are inadequate, so Anne Spichler and colleagues suggest that developing new molecular techniques to better understand DFI microbiology will lead to better management of this complex disease.
BMC Medicine: a decade of open access medical research
BMC Medicine 2014, 12:4 (9 January 2014)
It has been 10 years since we have been publishing open access medical research, so we take a look at some of the most notable milestones for the journal and our editorial board members discuss exciting developments in their own fields of medicine.
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
BMC Medicine 2013, 11:221 (17 October 2013)
Translation of tumor biomarker tests to clinical trials should be based on robust evidence; Dan Hayes discusses a new checklist that researchers should follow for stringent methodology, highlighting its importance for clinical application.
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
BMC Medicine 2013, 11:220 (17 October 2013)
Lisa McShane and colleagues present a checklist of criteria to address the lack of scientific rigor when evaluating preclinical evidence to support translation of omics-based predictors to clinical trials, providing a useful resource for researchers.